Remdesibir Approved as a new type of corona treatment on 7th May 0:00, Ministry of Health, Labor and Welfare
Minister of Health, Labor and Welfare Kato announced on the 7th that "lemdecivir", which is undergoing procedures for the first approval in Japan as a new coronavirus treatment, is being approved.
Regarding the new coronavirus treatment drug, the Ministry of Health, Labor and Welfare is proceeding with the “special approval” procedure for “lemdecivir” developed in the US, which simplifies the domestic review of drugs approved for use overseas.
In response to this, Minister of Health, Labor and Welfare Kato announced on a commercial TV program on the evening of the 5th, "There was an application for approval from an American pharmaceutical company yesterday. We will approve it in a while. "
In addition, in connection with the point that the distribution volume of lemdecivir is limited, "Pharmaceutical companies have not yet contacted us about how much it can supply to Japan. We will strive to secure more quantities, We want to be able to use it as soon as possible. "
In addition, Mr. Kato is discussing the increase in the maximum amount of the employment adjustment subsidy, saying, "Prime Minister Abe has indicated that he should consider it in the direction of increasing it. I haven't reached this point, but I would like to refer to cases from overseas such as the United Kingdom. "
Furthermore, regarding the extension of the emergency declaration by the end of this month, “Declaration may be canceled before the deadline in some regions, but in some cases, it is newly designated as a“ precautionary prefecture ”. There is a possibility that we will be required to take a strict response. We hope that this will not happen, and we would like to work hard.